Basics |
Company: |
Twist Bioscience Corporation |
IPO Date: |
October 29, 2018 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$2.46B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.78 | 3.42%
|
Avg Daily Range (30 D): |
$1.54 | 3.19%
|
Avg Daily Range (90 D): |
$1.39 | 2.99%
|
Institutional Daily Volume |
Avg Daily Volume: |
.65M |
Avg Daily Volume (30 D): |
.76M |
Avg Daily Volume (90 D): |
.67M |
Trade Size |
Avg Trade Size (Sh.): |
55 |
Avg Trade Size (Sh.) (30 D): |
46 |
Avg Trade Size (Sh.) (90 D): |
44 |
Institutional Trades |
Total Inst.Trades: |
2,523 |
Avg Inst. Trade: |
$3.35M |
Avg Inst. Trade (30 D): |
$2.62M |
Avg Inst. Trade (90 D): |
$3.22M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$5.48M |
Avg Closing Trade (30 D): |
$4.79M |
Avg Closing Trade (90 D): |
$5.58M |
Avg Closing Volume: |
130.93K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-3.38
|
$-.53
|
$-.59
|
Diluted EPS
|
$-3.38
|
$-.53
|
$-.59
|
Revenue
|
$ 330.19M
|
$ 88.71M
|
$ 84.71M
|
Gross Profit
|
$ 147.23M
|
$ 42.84M
|
$ 38.23M
|
Net Income / Loss
|
$ -197.31M
|
$ -31.59M
|
$ -34.66M
|
Operating Income / Loss
|
$ -208.5M
|
$ -34.64M
|
$ -36.04M
|
Cost of Revenue
|
$ 182.96M
|
$ 45.87M
|
$ 46.48M
|
Net Cash Flow
|
$ -45.06M
|
$ -5.07M
|
$ -12.91M
|
PE Ratio
|
|
|
|
|